Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
3
×
life sciences
national blog main
national top stories
3
×
new york blog main
san francisco blog main
deals
detroit blog main
detroit top stories
drugs
fda
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accelerator
age related macular degeneration
agios pharmaceuticals
airbnb
amazon web services (aws)
american society of hematology
artificial intelligence (a.i.)
athelas
atomwise
benchling
beta-thalassemia
biotech
biotechnology
blood diseases
What
big
3
×
acquire
admits
ago
agreed
american
ash
billion
biotechs
blood
broad
classes
combinator
companies
confidence
country
didn’t
diego
disease
dug
foundation
gain
gathering
genentech
hematology’s
incubator
largest
life
medical
medicine
meeting
momentum
morning
panels
pay
pays
picked
previewed
previously
profiling
Language
unset
Current search:
cancer
×
big
×
" national top stories "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine